Prevalence and Risk of Anemia in People With Multiple Sclerosis (MS): A Systematic Review and Meta‐Analysis

Le résumé fourni par la source

Introduction Anemia appears as a common comorbidity in a different timing and underlying pathophysiology in people with MS (PwMS) and has been proposed as a prodrome finding in MS. This systematic review and meta‐analysis aims to fulfill the need to clarify some characteristics of anemia in PwMS. Methods A systematic literature search was performed using the MEDLINE PubMed, Scopus, and Google Scholar databases. Eligible studies underwent quality assessment using the Robins‐E, and a meta‐analysis of proportion was performed. The risk of anemia in PwMS versus healthy controls was calculated based on a subset of case–control studies. Reliability and robustness were assessed using leave‐one‐out analysis. Results In a pool of 143,879 PwMS across 21 studies, anemia had a pooled prevalence of 12.5% (95% CI [8.1%, 17.7%], I 2 = 99.0%, p Q = 0). In a subset of five studies, the relative risk of anemia between PwMS and healthy controls was 2.9 (95% CI [1.45, 5.79], I 2 = 97.6%, p z = 0.002, p Q < 0.001) in favor of PwMS. Conclusion The intersection between anemia and MS presents a complex, multifaceted clinical challenge due to several pathophysiological mechanisms and DMT‐related interactions. Further structured studies are needed to evaluate the exact underlying mechanisms and the directionality of this relationship.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.